# CorriXR Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corrixr-therapeutics

- Industry: Biotechnology
- Headquarters: Newark, US
- Website: www.corrixr.com/
- Total disclosed funding: $2.5M
- Latest round: Seed (Jun 30, 2022)
- Investors on record: 3

## About

Based in Delaware, US, and founded in 2022, CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative research-based biotechnology company. The company was founded by its CEO Eric B Kmiec. In August 2025, CorriXR Therapeutics received 1 million from Delaware.

## Funding rounds

- Seed, Jun 30, 2022, $2.5M — Christiana Care Health System, Inc., Cortado Ventures, Brookhaven Bio

## Investors

- Christiana Care Health System, Inc. — Seed
- Cortado Ventures (https://capitalatlas.ai/funds/cortado-ventures) — Seed
- Brookhaven Bio — Seed